Xu, Yuan published the artcileDesign, synthesis and evaluation of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors, Application In Synthesis of 104-01-8, the main research area is aryl thiazolamine preparation acetylcholinesterase inhibitor; Acetylcholinesterase inhibitor; Alzheimer’s disease; Molecular docking.
A series of new 4-arylthiazole-2-amine derivatives I (m = 1,2,3,4; n = 0,1; R1 = pyrrolidin-1-yl, piperidin-1-yl, 1-benzylpiperidin-4-yl, etc.; R2 = H, OMe; R3 = OMe; R4 = H, OMe) as acetylcholinesterase inhibitors (AChEIs) were designed and synthesized, Furthermore, their inhibitory activities against acetylcholinesterase in vitro were tested by Ellman spectrophotometry, and the results of inhibitory activity test showed that most of them had a certain acetylcholinesterase inhibitory activity in vitro. Moreover, the IC50 value of compound I (m = 3; n = 1; R1 = pyrrolidin-1-yl; R2 = H; R3 = OMe; R4 = OMe) was 0.66μM, which was higher than that of Rivastigmine and Huperzine-A as reference compounds, and it had a weak inhibitory effect on butyrylcholinesterase. The potential binding mode of above compound with AChE was investigated by the mol. docking, and the results showed that it was strongly bound up with AChE with the optimal conformation, in addition, their binding energy reached -11.27 Kcal*mol-1. At last, in silico mol. property of the synthesized compounds were predicted by using Molinspiration online servers. It can be concluded that the lead AChEIs above compound presented satisfactory drug-like characteristics.
Bioorganic & Medicinal Chemistry Letters published new progress about Alzheimer disease. 104-01-8 belongs to class isoquinoline, name is 4-Methoxyphenylacetic acid, and the molecular formula is C9H10O3, Application In Synthesis of 104-01-8.
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem